Back to Search Start Over

Long-Term Cost-Effectiveness of Smoking Cessation Interventions in People With Mental Disorders: A Dynamic Decision Analytical Model.

Authors :
Wu, Qi
Gilbody, Simon
Li, Jinshuo
Wang, Han-I
Parrott, Steve
Source :
Value in Health. Sep2021, Vol. 24 Issue 9, p1263-1272. 10p.
Publication Year :
2021

Abstract

<bold>Objectives: </bold>People with mental disorders are more likely to smoke than the general population. The objective of this study is to develop a decision analytical model that estimates long-term cost-effectiveness of smoking cessation interventions in this population.<bold>Methods: </bold>A series of Markov models were constructed to estimate average lifetime smoking-attributable inpatient cost and expected quality-adjusted life-years. The model parameters were estimated using a variety of data sources. The model incorporated uncertainty through probabilistic sensitivity analysis using Monte Carlo simulations. It also generated tables presenting incremental cost-effectiveness ratios of the proposed interventions with varying incremental costs and incremental quit rates. We used data from 2 published trials to demonstrate the model's ability to make projections beyond the observational time frame.<bold>Results: </bold>The average smoker's smoking-attributable inpatient cost was 3 times higher and health utility was 5% lower than ex-smokers. The intervention in the trial with a statistically insignificant difference in quit rate (19% vs 25%; P=.2) showed a 45% to 49% chance of being cost-effective compared with the control at willingness-to-pay thresholds of £20 000 to £30 000/quality-adjusted life-years. The second trial had a significant outcome (quit rate 35.9% vs 15.6%; P<.001), and the corresponding probability of the intervention being cost-effective was 65%.<bold>Conclusions: </bold>This model provides a consistent platform for clinical trials to estimate the potential lifetime cost-effectiveness of smoking cessation interventions for people with mental disorders and could help commissioners direct resources to the most cost-effective programs. However, direct comparisons of results between trials must be interpreted with caution owing to their different designs and settings. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10983015
Volume :
24
Issue :
9
Database :
Academic Search Index
Journal :
Value in Health
Publication Type :
Academic Journal
Accession number :
152062203
Full Text :
https://doi.org/10.1016/j.jval.2021.04.002